Undecanol Overlay for 4-Vinylphenol Extraction in E. coli Fermentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing 4-vinylphenol from p-coumaric acid using phenolic acid decarboxylase enzymes in E. coli face challenges due to product toxicity and inhibition of enzyme activity, with solvents like hexane and octanol being effective for extraction but toxic to the host cells.
Innovation Solution
A method involving genetically modified host cells, such as engineered E. coli strains, that express phenolic acid decarboxylase enzymes, cultured in a medium with an organic overlay like undecanol to convert p-coumaric acid to 4-vinylphenol, allowing for high titer production and extraction of the product in the organic phase, reducing toxicity and inhibition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If hexane or octanol is used to extract 4-vinylphenol from the aqueous phase, then product extraction efficiency is improved, but host cell toxicity increases
Solution Approach 1:
The patent changes the physical parameter of the organic solvent by selecting undecanol (11 carbon atoms) instead of hexane (6 carbons) or octanol (8 carbons). This parameter change results in a solvent with lower toxicity to E. coli while maintaining effective extraction of 4-vinylphenol, thus resolving the contradiction between extraction efficiency and host cell viability
Solution Approach 2:
The patent employs a disposable organic overlay system where undecanol is added to the culture medium, performs extraction function, and can be easily removed or degraded. This approach allows continuous production without requiring complex recovery systems, effectively managing the toxicity issue while maintaining high extraction efficiency
2Productivity
If phenolic acid decarboxylase enzyme is used to convert p-coumaric acid to 4-vinylphenol, then product formation is improved, but enzyme activity inhibition occurs due to product toxicity
Solution Approach 1:
The patent introduces undecanol as an intermediary substance that mediates between the enzyme and the product. By partitioning the product into the organic phase, undecanol reduces the concentration of 4-vinylphenol in the aqueous phase where the enzyme operates, thereby preventing product inhibition while maintaining high productivity
Solution Approach 2:
The patent establishes a continuous extraction mechanism where undecanol continuously removes 4-vinylphenol from the reaction medium. This continuous action prevents product accumulation that would otherwise inhibit the enzyme, allowing the enzymatic conversion to proceed continuously at high rates without loss of activity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves high yields of 4-vinylphenol, with undecanol enabling efficient extraction and concentration, reaching titers of up to 187 g/L with over 90% yield, and allows for simple recovery via distillation, overcoming previous toxicity and inhibition issues.
Implementation Method 1
hexane and octanol are two organic solvents that have proven to be effective at extracting 4VP from the aqueous phase
Implementation Method 2
a phenolic acid decarboxylase (PAD) enzyme catalyzed by a phenolic acid decarboxylase (PAD) enzyme
Implementation Method 3
CA and FA can be decarboxylated to their vinylphenol derivatives
Implementation Method 4
the recovering step comprises distilling, such as low pressure or vacuum distilling, to separate the 4VP and/or 4VG from the saturated or unsaturated fatty alcohol
Data Source
AI summary
The present invention provides for a method for producing a 4-vinylphenol (4VP) and/or 4-vinylguaiacol (4VG), the method comprising: (a) providing a host cell capable of expressing a polypeptide having a phenolic acid decarboxylase (PAD) enzymatic activity wherein the polypeptide is capable of converting p-coumaric (CA) and/or ferulic acid (FA) into 4-vinylphenol (4VP) and/or 4-vinylguaiacol (4VG), respectively; and (b) culturing the host cell in a culture medium to express the polypeptide such that the polypeptide converts CA and/or FA into 4VP and/or 4VG, respectively; wherein the culture medium comprises an organic overlay or phase.